Cargando…

Reply to: Need for improvements in reported cost-effectiveness of adalimumab in rheumatoid arthritis

Detalles Bibliográficos
Autores principales:	Gissel, C., Götz, G., Repp, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Medizin 2017
Materias:	Leserbrief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344950/ https://www.ncbi.nlm.nih.gov/pubmed/28084541 http://dx.doi.org/10.1007/s00393-016-0256-2

Ejemplares similares

Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
por: Gissel, C., et al.
Publicado: (2016)

Riech- und Schmeckstörungen bei Epilepsien und anderen neurologischen Erkrankungen
por: Krämer, G.
Publicado: (2022)

Fragwürdiges Akronym
por: Lang, Christoph J. G.
Publicado: (2023)

Bestmögliche Balance zwischen dem Risiko für die Helfer und dem Nutzen für den Patienten
por: Hoffmann, F., et al.
Publicado: (2020)

Kinderreanimation während SARS-CoV-2-Pandemie – eine Balance zwischen Eigenschutz und Faktor Zeit
por: Jenke, A., et al.
Publicado: (2020)

Gefahr der Medikamentenverneblung bei COVID-19: viel Rauch um nichts?
por: Clemens, J.
Publicado: (2020)

Myalgien als Symptom der COVID-19-Erkrankung
por: Dieselhorst, V.
Publicado: (2020)

Jenseits von Husten und Pulsoxymetrie … Welche Symptome sind wichtig bei COVID-19?
por: Thomas-Rüddel, D., et al.
Publicado: (2020)

Wie lange dauert eine Langzeitanwendung?
por: Zenz, Michael
Publicado: (2020)

Kommentar der Multiple Sklerose Therapie Konsensus Gruppe (MSTKG) zur S2k-Leitlinie Multiple Sklerose
por: Wiendl, Heinz, et al.
Publicado: (2021)

Tranexamsäure und Endoprothetik: zwischen „off label use“ und „evidence-based medicine“
por: Lier, Heiko, et al.
Publicado: (2021)

Hohe Rückfallraten nach pandemiebedingtem Aussetzen der Erhaltungsbehandlung mittels Elektrokonvulsionstherapie. EKT ist keine elektive Therapie
por: Zilles-Wegner, David, et al.
Publicado: (2021)

Sepsis auf deutschen Intensivstationen – Weltweit Schlusslicht? … Nicht so schnell
por: Bauer, Michael, et al.
Publicado: (2021)

Die Rolle der farbkodierten Duplexsonographie zur präoperativen Gefäßdiagnostik in der plastischen Chirurgie
por: Vater, Adrian Matthias, et al.
Publicado: (2022)

Umsetzungsstand der Telefonreanimation und Einfluss der COVID-19-Pandemie
por: Rott, Nadine, et al.
Publicado: (2022)

Telefonreanimation: Selbsteinschätzungen laufen oft ins Leere
por: Marung, Hartwig, et al.
Publicado: (2022)

Pterygium: what about point of care biomarkers?
por: Rokohl, Alexander C., et al.
Publicado: (2021)

Postvirale Erkrankungen – die Neurologie sollte Farbe bekennen
por: Kleinschnitz, C.
Publicado: (2023)

Cost-effectiveness of Interferon-free therapy for Hepatitis C in Germany - an application of the efficiency frontier approach
por: Gissel, Christian, et al.
Publicado: (2015)

Cost-Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept
por: Gholami, Ahmad, et al.
Publicado: (2021)

Cost per responder of TNF-α therapies in Germany
por: Gissel, Christian, et al.
Publicado: (2013)

Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
por: Capsoni, Franco, et al.
Publicado: (2005)

Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
por: Schlueter, Max, et al.
Publicado: (2019)

Long-term treatment of rheumatoid arthritis with adalimumab
por: Murdaca, Giuseppe, et al.
Publicado: (2013)

Sweet’s Syndrome in a Patient With Seropositive Rheumatoid Arthritis After Starting Adalimumab: Is Sweet’s Syndrome Related to Rheumatoid Arthritis or Is It the Paradoxical Effect of Adalimumab?
por: Paul, Prodip, et al.
Publicado: (2021)

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalía, et al.
Publicado: (2011)

Beyond the joints in rheumatoid arthritis: Effects of adalimumab on hematologic and lipid indices
por: Sakthiswary, R., et al.
Publicado: (2012)

The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis
por: Incerti, Devin, et al.
Publicado: (2020)

Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
por: Zhao, Sizheng, et al.
Publicado: (2018)

Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia
por: Deakin, Claire T., et al.
Publicado: (2023)

Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
por: Genovese, Mark C., et al.
Publicado: (2016)

Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry
por: Pappas, Dimitrios A., et al.
Publicado: (2017)

Effects of Treatment with Adalimumab on Blood Lipid Levels and Atherosclerosis in Patients with Rheumatoid Arthritis
por: Bergström, Ulf, et al.
Publicado: (2018)

A Cost per Responder Model for Abatacept versus Adalimumab Among Rheumatoid Arthritis Patients with Seropositivity
por: Park, Sang Hee, et al.
Publicado: (2020)

Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab
por: Herenius, M M J, et al.
Publicado: (2011)

Regulatory T cells as a biomarker for response to adalimumab in rheumatoid arthritis
por: Nguyen, Dao X., et al.
Publicado: (2018)

Adalimumab-Induced Erythema Multiforme in a Patient With Rheumatoid Arthritis: A Case Report
por: Mohammed, Jinan Q, et al.
Publicado: (2022)

Treatment Patterns and Costs in Biologic DMARD-Naive Patients with Rheumatoid Arthritis Initiating Etanercept or Adalimumab with or Without Methotrexate
por: Tkacz, Joseph, et al.
Publicado: (2020)

Successful Treatment of Pseudoseptic Arthritis Contained Massive Purulent Fluid with Adalimumab in Rheumatoid Arthritis
por: Chung, Chong Hyuk, et al.
Publicado: (2020)

Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis
por: Chara, Luis, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6ibgsoo0dsubh9kjedg7ojpttd